CDEK
← All drugs Report issue

18f-jk-psma-7

PeptideexperimentalImaging agent

Clinical trial activity

8 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
4
Phase 3
3
Phase 4
1

Earliest trial started Jul 1, 2021 (NCT05841992)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2022

    Earliest Phase 3 Sponsor(trial)

  3. Jan 1, 2024

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07011342N/AOct 1, 2025Hackensack University Medical Center
NCT06479187Phase 4Jun 30, 2024Blue Earth Diagnostics, Harvard University
NCT05707182Early Phase 1 (Phase 1)Apr 30, 2024University of Alabama, Birmingham
NCT05799248Phase 3Apr 27, 2023Blue Earth Diagnostics, MidLantic Urology
NCT05779943Phase 2Apr 27, 2023Blue Earth Diagnostics, Emory University, National Cancer Institute (NCI)
NCT05622162Phase 3Nov 30, 2022Advice Pharma Group srl, ITEL Telecomunicazioni Srl
NCT05761366Phase 2Oct 13, 2022Chinese Academy of Medical Sciences
NCT05841992Phase 2/Phase 3 (Phase 3)Jul 1, 2021Chinese Academy of Medical Sciences
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Blue Earth DiagnosticsFor profit3032023
Chinese Academy of Medical SciencesAcademic/Hospital2222021
Advice Pharma Group srlFor profit1012022
Emory UniversityAcademic/Hospital1112023
Hackensack University Medical CenterAcademic/Hospital1112025
Harvard UniversityAcademic/Hospital1112024
ITEL Telecomunicazioni SrlFor profit1112022
MidLantic UrologyAcademic/Hospital1112023
National Cancer Institute (NCI)Government1012023
University of Alabama, BirminghamAcademic/Hospital1112024
10 organizations
Page 1 / 1